See Related Editorial on Page X

[1]  M. Manns,et al.  Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  T. Joh,et al.  Diagnosis of IgG4-related sclerosing cholangitis. , 2013, World journal of gastroenterology.

[3]  C. Gieger,et al.  Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 , 2013, Hepatology.

[4]  Umme-Aiman Halai,et al.  Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis , 2013, Digestive Diseases and Sciences.

[5]  K. Boberg,et al.  Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  U. Beuers,et al.  Advances in pathogenesis and treatment of pruritus. , 2013, Clinics in liver disease.

[7]  R. Chapman,et al.  Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. , 2013, Journal of hepatology.

[8]  M. Camilleri,et al.  Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis , 2013, United European gastroenterology journal.

[9]  R. Kerstens,et al.  Effect of prucalopride on symptoms of chronic constipation , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  J. Tack,et al.  Levels of satisfaction with current chronic constipation treatment options in Europe – an internet survey , 2013, Alimentary pharmacology & therapeutics.

[11]  P. Holzer.  Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? , 2012, Current pharmaceutical design.

[12]  X. Hou,et al.  Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  S. Pereira,et al.  Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience , 2012, European journal of gastroenterology & hepatology.

[14]  J. Cuppoletti,et al.  Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl− Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl− Currents , 2012, Cell Biochemistry and Biophysics.

[15]  D. Schuppan,et al.  CFTR dysfunction predisposes to fibrotic liver disease in a murine model. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[16]  K. Lindor,et al.  Pathogenesis and management of pruritus in cholestatic liver disease , 2012, Journal of gastroenterology and hepatology.

[17]  D. Goldberg,et al.  Lack of Standardization in Exception Points for Patients With Primary Sclerosing Cholangitis and Bacterial Cholangitis , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  K. Reddy,et al.  Pruritus in chronic cholestatic liver disease. , 2012, Clinics in liver disease.

[19]  K. Lindor,et al.  Likelihood of Malignancy in Gallbladder Polyps and Outcomes Following Cholecystectomy in Primary Sclerosing Cholangitis , 2012, The American Journal of Gastroenterology.

[20]  R. Chapman,et al.  A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease. , 2012, Journal of Crohn's & colitis.

[21]  W. Chey,et al.  Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation , 2012, Alimentary pharmacology & therapeutics.

[22]  J. Camm,et al.  Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study , 2012, British journal of clinical pharmacology.

[23]  T. Karlsen,et al.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. , 2012, World journal of gastroenterology.

[24]  K. Lindor,et al.  The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis – a pilot study , 2012, Alimentary pharmacology & therapeutics.

[25]  K. Jhaveri,et al.  The Spectrum of Sclerosing Cholangitis and the Relevance of IgG4 Elevations in Routine Practice , 2012, The American Journal of Gastroenterology.

[26]  B. Portmann,et al.  Inflammatory disease of the bile ducts–cholangiopathies: liver biopsy challenge and clinicopathological correlation , 2012, Histopathology.

[27]  K. Sung,et al.  Hepatic arterial injuries in 3110 patients following percutaneous transhepatic biliary drainage. , 2011, Radiology.

[28]  G. Gores,et al.  Cancer surveillance in patients with primary sclerosing cholangitis , 2011, Hepatology.

[29]  Alexander Meining,et al.  Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience. , 2011, Gastrointestinal endoscopy.

[30]  Jesse S. Voss,et al.  Primary Sclerosing Cholangitis Patients With Serial Polysomy Fluorescence In Situ Hybridization Results Are at Increased Risk of Cholangiocarcinoma , 2011, The American Journal of Gastroenterology.

[31]  A. Ford,et al.  Prevalence of, and Risk Factors for, Chronic Idiopathic Constipation in the Community: Systematic Review and Meta-analysis , 2011, The American Journal of Gastroenterology.

[32]  E. Björnsson,et al.  Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population‐based cohort , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[33]  S. Azad,et al.  Pharmacology of peripheral opioid receptors , 2011, Current opinion in anaesthesiology.

[34]  W. Saad,et al.  Obliteration of bleeding peristomal varices with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. , 2011, Journal of vascular and interventional radiology : JVIR.

[35]  W. Kim,et al.  Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  E. Michna,et al.  Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study. , 2011, The journal of pain : official journal of the American Pain Society.

[37]  E. Björnsson,et al.  Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[38]  M. Camilleri,et al.  Lubiprostone for the treatment of opioid-induced bowel dysfunction , 2011, Expert opinion on pharmacotherapy.

[39]  W. Melvin,et al.  Lubiprostone Reverses the Inhibitory Action of Morphine on Mucosal Secretion in Human Small Intestine , 2011, Digestive Diseases and Sciences.

[40]  M. Hopp,et al.  Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials , 2010, BMC clinical pharmacology.

[41]  M. Dave,et al.  Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. , 2010, Radiology.

[42]  Rajeev Sharma,et al.  Living Donor and Deceased Donor Liver Transplantation for Autoimmune and Cholestatic Liver Diseases—An Analysis of the UNOS Database , 2010, Journal of Gastrointestinal Surgery.

[43]  S. Greenfield,et al.  Systematic review: impact of constipation on quality of life in adults and children , 2010, Alimentary pharmacology & therapeutics.

[44]  D. Gotthardt,et al.  Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. , 2010, Gastrointestinal endoscopy.

[45]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[46]  D. Dubois,et al.  Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation – Quality of Life questionnaire in prucalopride (RESOLOR®) trials for chronic constipation , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[47]  E. Castle,et al.  Direct Percutaneous Embolization of Bleeding Stomal Varices , 2010, CardioVascular and Interventional Radiology.

[48]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[49]  M. Camilleri,et al.  Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[50]  B. Petersen,et al.  Complications of Endoscopic Retrograde Cholangiopancreatography in Primary Sclerosing Cholangitis , 2009, The American Journal of Gastroenterology.

[51]  G. Pasternak,et al.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.

[52]  Natalie J Torok,et al.  Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study , 2009, The American Journal of Gastroenterology.

[53]  R. Kerstens,et al.  Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives , 2008, Gut.

[54]  K. Lindor,et al.  Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis , 2008, Hepatology.

[55]  M. Kamm,et al.  A multinational survey of prevalence and patterns of laxative use among adults with self‐defined constipation , 2008, Alimentary pharmacology & therapeutics.

[56]  K. Cox,et al.  Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic , 2008, Journal of pediatric gastroenterology and nutrition.

[57]  M. Camilleri,et al.  A placebo-controlled trial of prucalopride for severe chronic constipation. , 2008, The New England journal of medicine.

[58]  B. Petersen,et al.  Prospective Evaluation of Advanced Molecular Markers and Imaging Techniques in Patients With Indeterminate Bile Duct Strictures , 2008, The American Journal of Gastroenterology.

[59]  S. Datta,et al.  Opioid complications and side effects. , 2008, Pain physician.

[60]  K. Lindor,et al.  Recurrence of primary sclerosing cholangitis: What do we learn from several transplant centers? , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[61]  J. Trotter,et al.  Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[62]  M. Malinchoc,et al.  Fractures and avascular necrosis before and after orthotopic liver transplantation: Long‐term follow‐up and predictive factors , 2007, Hepatology.

[63]  A. Sanyal,et al.  Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. , 2007, The American journal of gastroenterology.

[64]  E. Björnsson,et al.  Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature , 2007, Hepatology.

[65]  J. Talwalkar,et al.  Tacrolimus for the treatment of primary sclerosing cholangitis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[66]  B. Lacy,et al.  Lubiprostone: a chloride channel activator. , 2007, Journal of clinical gastroenterology.

[67]  A. Befeler,et al.  High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis , 2007, Current gastroenterology reports.

[68]  J. Johanson,et al.  Chronic constipation: a survey of the patient perspective , 2007, Alimentary pharmacology & therapeutics.

[69]  Michael Pasternack,et al.  The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph. , 2007, European journal of pharmacology.

[70]  A. Krasinskas,et al.  Liver Transplantation in Precirrhotic Biliary Tract Disease: Portal Hypertension is Frequently Associated With Nodular Regenerative Hyperplasia and Obliterative Portal Venopathy , 2006, The American journal of surgical pathology.

[71]  T. Smyrk,et al.  Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis , 2006, The American Journal of Gastroenterology.

[72]  M. Manns,et al.  Cholangioscopic Characterization of Dominant Bile Duct Stenoses in Patients with Primary Sclerosing Cholangitis , 2006, Endoscopy.

[73]  K. Boberg,et al.  Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[74]  K. Saeian,et al.  Primary sclerosing cholangitis treated by endoscopic biliary dilation: Review and long-term follow-up evaluation , 2006, Current gastroenterology reports.

[75]  A. Stiehl.  Primary sclerosing cholangitis: the role of endoscopic therapy. , 2006, Seminars in liver disease.

[76]  R. Shah,et al.  Is There a Role for Cholangioscopy in Patients with Primary Sclerosing Cholangitis? , 2006, The American Journal of Gastroenterology.

[77]  K. Boberg,et al.  High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. , 2005, Gastroenterology.

[78]  K. Lindor,et al.  Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo‐controlled trial , 2005, Hepatology.

[79]  P. Malfertheiner,et al.  Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. , 2005, Journal of clinical gastroenterology.

[80]  F. Nevens,et al.  Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2005, Journal of hepatology.

[81]  R. Moore,et al.  Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids , 2005, Arthritis research & therapy.

[82]  K. Lindor,et al.  Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis , 2005, The American Journal of Gastroenterology.

[83]  M. Manns,et al.  Characterization, Outcome, and Prognosis in 273 Patients with Primary Sclerosing Cholangitis: A Single Center Study , 2005, The American Journal of Gastroenterology.

[84]  O. Chassany,et al.  Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire , 2005, Scandinavian journal of gastroenterology.

[85]  M. Färkkilä,et al.  Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo‐controlled trial , 2004, Hepatology.

[86]  B. Petersen,et al.  Cost‐minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis , 2004, Hepatology.

[87]  K. Lindor,et al.  Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[88]  R. Kozarek.  Endoscopic Therapy in Primary Sclerosing Cholangitis. Dominant Strictures May Not Matter: Does that Mean that Endotherapy Does Not Work? , 2004, American Journal of Gastroenterology.

[89]  E. Björnsson,et al.  Dominant Strictures in Patients with Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[90]  K. Lindor,et al.  Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis , 2004, Hepatology.

[91]  E. Kalso,et al.  Recommendations for using opioids in chronic non‐cancer pain , 2003, European journal of pain.

[92]  K. Lindor,et al.  Is there a role for liver biopsy in primary sclerosing cholangitis? , 2003, American Journal of Gastroenterology.

[93]  S. E.,et al.  Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients , 2003 .

[94]  R. Chuttani,et al.  Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures. , 2002, Gastrointestinal endoscopy.

[95]  A. Bergquist,et al.  Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.

[96]  K. Boberg,et al.  Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis , 2002, Gut.

[97]  E. Irvine,et al.  Health-related quality of life in functional GI disorders: focus on constipation and resource utilization , 2002, American Journal of Gastroenterology.

[98]  P. Heidenreich,et al.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.

[99]  K. Lindor,et al.  Small‐duct primary sclerosing cholangitis: A long‐term follow‐up study , 2002, Hepatology.

[100]  G. Gores,et al.  In primary sclerosing cholangitis, gallbladder polyps are frequently malignant , 2002, American Journal of Gastroenterology.

[101]  G. Reynolds,et al.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. , 2002, The American journal of pathology.

[102]  P. Sauer,et al.  Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. , 2002, Journal of hepatology.

[103]  D. Adams,et al.  Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease , 2002, The Lancet.

[104]  R. Chapman,et al.  A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. , 2001, Gastroenterology.

[105]  N. Chalasani,et al.  Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. , 2001, Gastrointestinal endoscopy.

[106]  D. Vergani,et al.  Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study , 2001, Hepatology.

[107]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[108]  N F LaRusso,et al.  Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. , 2000, Journal of hepatology.

[109]  K. Batts,et al.  Oral budesonide in the treatment of primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[110]  N. LaRusso,et al.  A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[111]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[112]  B. Petersen,et al.  Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[113]  N. LaRusso,et al.  High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[114]  G. Gores,et al.  Biliary tract cancers. , 1999, The New England journal of medicine.

[115]  K. Lindor,et al.  Serum autoantibodies in patients with primary sclerosing cholangitis. , 2000, Journal of hepatology.

[116]  P. Schirmacher,et al.  Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series , 1999, Annals of Internal Medicine.

[117]  G. Gores,et al.  Long‐term results of patients undergoing liver transplantation for primary sclerosing cholangitis , 1999, Hepatology.

[118]  T. Therneau,et al.  Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. , 1998, Journal of hepatology.

[119]  J. Dahlerup,et al.  Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography , 1998, Hepatology.

[120]  E. Björnsson,et al.  Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. , 1998, Journal of hepatology.

[121]  A. Ekbom,et al.  Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. , 1997, Scandinavian journal of gastroenterology.

[122]  G. Tytgat,et al.  Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. , 1997, Gastrointestinal endoscopy.

[123]  G. Gores,et al.  Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? , 1997, Journal of hepatology.

[124]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.

[125]  R. Wiesner,et al.  Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. , 1996, Mayo Clinic proceedings.

[126]  K. Boberg,et al.  Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis , 1996, Hepatology.

[127]  E. Dickson,et al.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. , 1995, The Journal of clinical investigation.

[128]  R. Wiesner,et al.  Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. , 1995, Journal of clinical gastroenterology.

[129]  P. Cotton,et al.  Endoscopic therapy of sclerosing cholangitis , 1995, Hepatology.

[130]  B. Malassagne,et al.  Primary sclerosing cholangitis: liver transplantation or biliary surgery. , 1995, Surgery.

[131]  E. Dickson,et al.  Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference? , 1995, Hepatology.

[132]  E. Moreno‐González,et al.  Caustic sclerosing cholangitis. Report of four cases and a cumulative review of the literature. , 1994, Hepato-gastroenterology.

[133]  H. Rousseau,et al.  Treatment of bleeding stomal varices using transjugular intrahepatic portosystemic shunt. , 1994, Journal of pediatric gastroenterology and nutrition.

[134]  M. Kaplan,et al.  A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. , 1994, Gastroenterology.

[135]  F. Carnot,et al.  Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. , 1993, The New England journal of medicine.

[136]  H. Waldum.  Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. , 1992, Journal of hepatology.

[137]  S. Trerotola,et al.  Hemobilia after percutaneous transhepatic biliary drainage: treatment with transcatheter embolotherapy. , 1992, Journal of vascular and interventional radiology : JVIR.

[138]  P. Grambsch,et al.  Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis , 1989, Hepatology.

[139]  G. Hommel.  A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[140]  H. Pitt,et al.  Resection of Hepatic Duct Bifurcation and Transhepatic Stenting for Sclerosing Cholangitis , 1988, Annals of surgery.

[141]  R. Groszmann,et al.  Interaction of flow and resistance in maintenance of portal hypertension in a rat model. , 1986, The American journal of physiology.

[142]  R. Recker,et al.  Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. , 1982, Gastroenterology.

[143]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[144]  R. E. Fulton,et al.  The ileal stoma and protal hypertension: an uncommon site of variceal bleeding. , 1977, Archives of surgery.

[145]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[146]  H. Pitt,et al.  Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. , 2011, Gastrointestinal endoscopy.

[147]  M. Davies,et al.  Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients. , 2011, AJR. American journal of roentgenology.

[148]  Christian Gieger,et al.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci , 2011, Nature Genetics.

[149]  E. Bjornsson,et al.  Bone disease in patients with primary sclerosing cholangitis. , 2011, Gastroenterology.

[150]  K. Lindor,et al.  High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis , 2011, The American Journal of Gastroenterology.

[151]  C. Wijmenga,et al.  Genome-wide association analysis in primary sclerosing cholangitis. , 2010, Gastroenterology.

[152]  Christine Miaskowski,et al.  The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). , 2009, Pain medicine.

[153]  R. Gasser.  Cholestasis and metabolic bone disease – a clinical review , 2008, Wiener Medizinische Wochenschrift.

[154]  A. Zinsmeister,et al.  FUNCTIONAL BOWEL DISORDERS , 2007, The American Journal of Gastroenterology.

[155]  T. Kamisawa.  IgG4-related sclerosing disease. , 2006, Internal medicine.

[156]  Ich Harmonised,et al.  INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .

[157]  N. LaRusso,et al.  Oral Nicotine in Treatment of Primary Sclerosing Cholangitis (A Pilot Study) , 2004, Digestive Diseases and Sciences.

[158]  R. Wiesner,et al.  Pirfenidone in the Treatment of Primary Sclerosing Cholangitis , 2004, Digestive Diseases and Sciences.

[159]  R. Groszmann,et al.  Nitric Oxide and Portal Hypertension: Its Role in the Regulation of Intrahepatic and Splanchnic Vascular Resistance , 1999, Seminars in liver disease.

[160]  L. Taylor,et al.  Psychometric validation of a constipation symptom assessment questionnaire. , 1999, Scandinavian journal of gastroenterology.

[161]  K. Lazaridis,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[162]  K. Lindor.  Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. , 1997, The New England journal of medicine.

[163]  R. Vaughan,et al.  Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. , 1992, Hepatology.

[164]  W. Hogan,et al.  Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment. , 1991, Gastrointestinal endoscopy.

[165]  M. Scheurlen,et al.  [Methotrexate in the therapy of primary biliary cirrhosis]. , 1991, Deutsche medizinische Wochenschrift.